Influence of geographic access and socioeconomic characteristics on breast cancer outcomes: A systematic review.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 03 06 2021
accepted: 28 06 2022
entrez: 19 7 2022
pubmed: 20 7 2022
medline: 22 7 2022
Statut: epublish

Résumé

Socio-economic and geographical inequalities in breast cancer mortality have been widely described in European countries and the United States. To investigate the combined effects of geographic access and socio-economic characteristics on breast cancer outcomes, a systematic review was conducted exploring the relationships between: (i) geographic access to healthcare facilities (oncology services, mammography screening), defined as travel time and/or travel distance; (ii) breast cancer-related outcomes (mammography screening, stage of cancer at diagnosis, type of treatment and rate of mortality); (iii) socioeconomic status (SES) at individuals and residential context levels. In total, n = 25 studies (29 relationships tested) were included in our systematic review. The four main results are: The statistical significance of the relationship between geographic access and breast cancer-related outcomes is heterogeneous: 15 were identified as significant and 14 as non-significant. Women with better geographic access to healthcare facilities had a statistically significant fewer mastectomy (n = 4/6) than women with poorer geographic access. The relationship with the stage of the cancer is more balanced (n = 8/17) and the relationship with cancer screening rate is not observed (n = 1/4). The type of measures of geographic access (distance, time or geographical capacity) does not seem to have any influence on the results. For example, studies which compared two different measures (travel distance and travel time) of geographic access obtained similar results. The relationship between SES characteristics and breast cancer-related outcomes is significant for several variables: at individual level, age and health insurance status; at contextual level, poverty rate and deprivation index. Of the 25 papers included in the review, the large majority (n = 24) tested the independent effect of geographic access. Only one study explored the combined effect of geographic access to breast cancer facilities and SES characteristics by developing stratified models.

Identifiants

pubmed: 35853035
doi: 10.1371/journal.pone.0271319
pii: PONE-D-21-10021
pmc: PMC9295987
doi:

Types de publication

Journal Article Systematic Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0271319

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Int J Health Geogr. 2016 Feb 18;15:8
pubmed: 26892310
Breast Cancer Res Treat. 2015 Jan;149(1):199-209
pubmed: 25472915
J Natl Cancer Inst. 2007 Sep 19;99(18):1384-94
pubmed: 17848670
Prof Geogr. 2008 Feb;60(1):54-69
pubmed: 18458760
Health Place. 2013 May;21:110-21
pubmed: 23454732
Public Health Rep. 2002 May-Jun;117(3):201-17
pubmed: 12432132
AJR Am J Roentgenol. 2013 Nov;201(5):1057-63
pubmed: 23952790
Worldviews Evid Based Nurs. 2004;1(3):176-84
pubmed: 17163895
Int J Cancer. 2006 Sep 1;119(5):1145-51
pubmed: 16557599
J Health Dispar Res Pract. 2013 Spring;6(1):70
pubmed: 24466505
Health Place. 2010 Mar;16(2):321-30
pubmed: 19959392
J Am Geriatr Soc. 2002 Jan;50(1):62-8
pubmed: 12028248
ANZ J Surg. 2017 Nov;87(11):E183-E187
pubmed: 27490767
J Womens Health (Larchmt). 2014 Aug;23(8):664-74
pubmed: 24865409
Womens Health Issues. 2015 Sep-Oct;25(5):482-93
pubmed: 26219677
Health Equity. 2018 Jul 01;2(1):109-116
pubmed: 30283856
Prev Med. 2012 Mar-Apr;54(3-4):259-65
pubmed: 22296836
BMC Public Health. 2013 Sep 10;13:823
pubmed: 24015917
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Int J Environ Res Public Health. 2016 Jul 19;13(7):
pubmed: 27447656
Eur J Cancer. 2008 Jan;44(2):269-74
pubmed: 17888651
J Rural Health. 2017 Apr;33(2):146-157
pubmed: 26987939
Geospat Health. 2018 May 07;13(1):622
pubmed: 29772881
Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2579-99
pubmed: 19815634
Health Place. 2010 Sep;16(5):1038-52
pubmed: 20630792
J Urban Health. 2009 Mar;86(2):196-213
pubmed: 18972211
Int J Health Geogr. 2016 Jul 28;15(1):23
pubmed: 27465415
PLoS One. 2018 Oct 31;13(10):e0205253
pubmed: 30379833
Breast. 2017 Dec;36:60-66
pubmed: 28985515
Cancer. 2008 Aug 1;113(3):582-91
pubmed: 18613122
Med Care. 2015 Nov;53(11):980-8
pubmed: 26465126
Cancer. 2006 Jan 1;106(1):201-7
pubmed: 16311987
Environ Plann B Plann Des. 2011 Aug;38(4):726-740
pubmed: 23335830
Womens Health Issues. 2012 May-Jun;22(3):e267-76
pubmed: 22265181
Rural Remote Health. 2010 Apr-Jun;10(2):1361
pubmed: 20438282
CA Cancer J Clin. 2004 Mar-Apr;54(2):78-93
pubmed: 15061598
Int J Cancer. 2013 Nov;133(9):2192-200
pubmed: 23595777
Matern Child Health J. 2018 Jan;22(1):101-110
pubmed: 28780684
Health Place. 2008 Sep;14(3):424-33
pubmed: 17951094
Cancer Causes Control. 2006 Aug;17(6):851-6
pubmed: 16783613
J Community Health. 2011 Dec;36(6):933-42
pubmed: 21461957
PLoS One. 2012;7(8):e43000
pubmed: 22952626
J Rural Health. 2009 Fall;25(4):366-71
pubmed: 19780916
J Am Coll Radiol. 2016 Jun;13(6):611-9
pubmed: 27026577
Breast J. 2009 Mar-Apr;15(2):216-7
pubmed: 19292817
BMC Cancer. 2009 Oct 14;9:364
pubmed: 19828016
Br J Cancer. 2006 Jan 16;94(1):152-5
pubmed: 16404368
J Epidemiol Community Health. 2013 Oct;67(10):861-7
pubmed: 23851149
Int J Public Pol. 2010;5(2-3):237-258
pubmed: 23316251

Auteurs

Benoit Conti (B)

LVMT, Université Gustave Eiffel, Ecole des Ponts, Champs-sur-Marne, France.

Audrey Bochaton (A)

Université Paris Nanterre, UMR 7533 LADYSS, Nanterre, France.

Hélène Charreire (H)

Université Paris-Est, Lab'Urba, France.
Institut Universitaire de France (IUF), Paris, France.

Hélène Kitzis-Bonsang (H)

Hôpital Privé des Peupliers, Ramsay Santé, Paris, France.

Caroline Desprès (C)

Centre de recherche des Cordeliers, Sorbonne Université, Université de Paris, INSERM, Equipe Etres, France.

Sandrine Baffert (S)

CEMKA, Paris, France.

Charlotte Ngô (C)

Hôpital Privé des Peupliers, Ramsay Santé, Paris, France.
Centre de recherche des Cordeliers, Sorbonne Université, Université de Paris, INSERM, Equipe Etres, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH